Vaxxinity Alzheimer's vaccine fast-tracked

Another Alzheimer’s Vaccine Moves Closer to Human Trials

By | December 31st, 2019

With repeated drug failures to treat Alzheimer’s disease in recent years, scientists are racing to find a vaccine to prevent the disease from evolving. The latest study was tested on mice genetically programmed to get Alzheimer’s disease and was successful in removing beta-amyloid plaque and tau protein linked to Alzheimer’s disease in the animals.

This latest vaccine study was conducted by researchers at the University of California Irvine and used an adjuvant or an immunological agent that boosts the immune response of the vaccine, formulated by Flinders University in South Australia.

“Our approach is looking to cover all bases and get past previous roadblocks in finding a therapy to slow the accumulation of amyloid beta/tau molecules and delay Alzheimer’s disease progression in a the rising number of people around the world,” says Flinders University Professor Petrovsky, who will work in the US for the next three months.

Potential Vaccine Targets Both Plaques and Tangles in Brain

The dual vaccine strategy prevents the formation of amyloid plaques and tau neurofibrillary tangles, two hallmarks associated with the progression of Alzheimer’s disease. Amyloid plaque are sticky clusters that form in spaces between nerve cells in the brain tissue.

Imaging research in recent years has proved that people can live with plaque in their brains decades before seeing a symptom of Alzheimer’s. Neurofibrillary tangles are knots of tau protein threads within the brain tissue. Both are believed to play a significant role in the pathology of Alzheimer’s disease. However, it remains unclear whether both of these structures cause Alzheimer’s or are a byproduct of the disease.

Researchers say the success of the animal study comes after two decades of working on the vaccine and could pave the way for human trials to start as early as 2021. Trial centers will be located in the United States but Professor Petrovsky told Australian media he hopes to make them available in Australia as well.

The Race to Find an Alzheimer’s Vaccine

This latest study is one of several recent ones attempting to develop a successful vaccine that works on humans. Earlier this year researchers from the University of New Mexico announced they successfully engineered a vaccine that prevents the formation of new tau tangles in the brain and eliminates existing ones in mice. And United Neurosciences, a Dublin-based biotech firm, announced it was seeing promising results in UB-311, in a clinical phase 2a human trial.

Earlier studies of anti-amyloid drugs have failed because they have caused brain swelling. It is hoped that a vaccine could trigger an immune response that doesn’t result in swelling. Past vaccine studies have targeted people over 60 years old who show signs of mild cognitive impairment.

If you find our articles and interviews helpful, please consider becoming a supporting member of our community. Frustrated by the lack of an editorially independent source of information on brain health and Alzheimer’s disease, we decided to create Being Patient. We are a team of dedicated journalists covering the latest research on Alzheimer’s, bringing you access to the experts and elevating the patient perspective on what it’s like to live with dementia.

Please help support our mission.

9 thoughts on “Another Alzheimer’s Vaccine Moves Closer to Human Trials

  1. The problem is the old age adage “is it the chicken or the egg”. The amyloid-beta and tau my be some later consequences of the underlying problem of Alzheimer’s. Akin to fever that accompanies pneumonia, getting rid of the fever with aspirin will do nothing to prevent the ongoing infection. Passive immunity drugs have all failed, why would active immunity with vaccination work?

    1. My father is getting worse and he was diagnosed with psp and i was wondering if that trial works for him. if so please enroll him . also wondering if this treatment help his speech as well.

  2. I am very interested in enrolling in one of these trials when they become available. Currently I have MCI

  3. I would like to know if you are looking for volunteers? My father is not getting better and I would love to try this new drug?

    1. Hello Aidan, this vaccine is not ready for human trials. Vaccines provide immunity to a disease before it a person is diagnosed.
      Consult Your Physician – Being Patient does not give medical advice, nor is any information on the site intended to be prescriptive medical advice. If you have any questions about your health or the health of your loved one, please consult your physician for any and all medical-related questions. ~ Thank you.

  4. Alzheimers runs deeply in my family. Just lost my Dad and Grandmother to it. Scared to death of not remembering who I am daily!

  5. I would be willing to try your new product. My mother n a uncle were blessed with this horrible disease. I have worked in an assisted living facility and seen what it does to families along what I seen it do to my family. Please consider me. I have a fear of this disease.

  6. My Daughter has suffered with Alzheimer’s for seven years my only wish is to see her cured before I die. I truly hope and prayer this vaccine you are working on is the answer to my prayers and too millions of others prayers. Losing your love one to this disease is so heartbreaking

Leave a Reply

We are glad you have chosen to leave a comment. Please keep in mind that comments are moderated according to our comment policy.